REGISTRIES

Open Access
Effectiveness of Rituximab for the Treatment of Rheumatoid Arthritis in Patients with Prior Exposure to Anti-TNF: Results from the CORRONA Registry
Leslie R. Harrold, George W. Reed, Ashwini Shewade, Robert Magner, Katherine C. Saunders, Ani John, Joel M. Kremer and Jeffrey D. Greenberg

The Journal of Rheumatology July 1 2015, 42 (7) 1090-1098; DOI: https://doi.org/10.3899/jrheum.141043
You have access
The Cost of Research: A Survey of Participating Sites in a Nationwide Registry
Jenna L. Tress and David D. Sherry

The Journal of Rheumatology April 1 2015, 42 (4) 702-705; DOI: https://doi.org/10.3899/jrheum.141122
You have access
Adalimumab, Etanercept, Infliximab, and the Risk of Tuberculosis: Data from Clinical Trials, National Registries, and Postmarketing Surveillance
Fabrizio Cantini, Laura Niccoli and Delia Goletti

The Journal of Rheumatology Supplement May 1 2014, 91 47-55; DOI: https://doi.org/10.3899/jrheum.140102
You have access
Comparative Effectiveness of Nonbiologic versus Biologic Disease-modifying Antirheumatic Drugs for Rheumatoid Arthritis
ESI MORGAN DEWITT, YANHONG LI, JEFFREY R. CURTIS, HENRY A. GLICK, JEFFREY D. GREENBERG, KEVIN J. ANSTROM, JOEL M. KREMER, GEORGE REED, KEVIN A. SCHULMAN and SHELBY D. REED

The Journal of Rheumatology February 1 2013, 40 (2) 127-136; DOI: https://doi.org/10.3899/jrheum.120400

Main menu